Morning Seminar May 28, 2009

Blood 2009;113:5083
Acute mixed lineage leukemia in children: The experience of St. Jude Children's Research Hospital.
Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, Behm FG, Campana D, Razzouk BI, Ribeiro RC, Downing JR, Pui CH.

Morning Seminar May 26, 2009

Clin Infect Dis. 2004 Jul 1;39(1):31-7.
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL.

Morning Seminar May 21, 2009

J Clin Oncol. 2009 Mar 10;27(8):1304-9.
Early and late mortality after diagnosis of wilms tumor.
Cotton CA, Peterson S, Norkool PA, Takashima J, Grigoriev Y, Breslow NE.

Morning Seminar May 19, 2009

Pediatr Hematol Oncol. 2008 Dec;25(8):705-22.
Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R.

Morning Seminar May 12, 2009

Leukemia. 2008 Apr;22(4):771-82.
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S, Stanulla M, Basso G, Niggli FK, Schäfer BW, Sutton R, Koehler R, Zimmermann M, Valsecchi MG, Gadner H, Masera G, Schrappe M, van Dongen JJ, Biondi A, Bartram CR; International BFM Study Group (I-BFM-SG).